nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—liver cancer	0.899	1	CbGaD
Dicyclomine—Tachyarrhythmia—Epirubicin—liver cancer	0.00419	0.0479	CcSEcCtD
Dicyclomine—Tachyarrhythmia—Doxorubicin—liver cancer	0.00388	0.0443	CcSEcCtD
Dicyclomine—Drug hypersensitivity—Epirubicin—liver cancer	0.0019	0.0217	CcSEcCtD
Dicyclomine—Drug hypersensitivity—Doxorubicin—liver cancer	0.00176	0.0201	CcSEcCtD
Dicyclomine—Mood swings—Sorafenib—liver cancer	0.00142	0.0163	CcSEcCtD
Dicyclomine—Breast disorder—Sorafenib—liver cancer	0.00136	0.0155	CcSEcCtD
Dicyclomine—Erectile dysfunction—Sorafenib—liver cancer	0.0012	0.0137	CcSEcCtD
Dicyclomine—Paralysis—Epirubicin—liver cancer	0.0011	0.0126	CcSEcCtD
Dicyclomine—Thrombosis—Epirubicin—liver cancer	0.00108	0.0124	CcSEcCtD
Dicyclomine—Dermatitis atopic—Epirubicin—liver cancer	0.00103	0.0118	CcSEcCtD
Dicyclomine—Paralysis—Doxorubicin—liver cancer	0.00102	0.0117	CcSEcCtD
Dicyclomine—Thrombosis—Doxorubicin—liver cancer	0.001	0.0114	CcSEcCtD
Dicyclomine—Necrosis—Epirubicin—liver cancer	0.000975	0.0111	CcSEcCtD
Dicyclomine—Cardiac disorder—Sorafenib—liver cancer	0.000965	0.011	CcSEcCtD
Dicyclomine—Dermatitis atopic—Doxorubicin—liver cancer	0.000957	0.0109	CcSEcCtD
Dicyclomine—Ageusia—Epirubicin—liver cancer	0.000945	0.0108	CcSEcCtD
Dicyclomine—Immune system disorder—Sorafenib—liver cancer	0.00094	0.0107	CcSEcCtD
Dicyclomine—Mediastinal disorder—Sorafenib—liver cancer	0.000938	0.0107	CcSEcCtD
Dicyclomine—Mental disorder—Sorafenib—liver cancer	0.000911	0.0104	CcSEcCtD
Dicyclomine—Erythema—Sorafenib—liver cancer	0.000906	0.0104	CcSEcCtD
Dicyclomine—Necrosis—Doxorubicin—liver cancer	0.000903	0.0103	CcSEcCtD
Dicyclomine—Delirium—Epirubicin—liver cancer	0.00089	0.0102	CcSEcCtD
Dicyclomine—Ageusia—Doxorubicin—liver cancer	0.000874	0.00999	CcSEcCtD
Dicyclomine—Angioedema—Sorafenib—liver cancer	0.000827	0.00946	CcSEcCtD
Dicyclomine—Delirium—Doxorubicin—liver cancer	0.000824	0.00941	CcSEcCtD
Dicyclomine—Dyskinesia—Epirubicin—liver cancer	0.000815	0.00931	CcSEcCtD
Dicyclomine—Syncope—Sorafenib—liver cancer	0.000812	0.00928	CcSEcCtD
Dicyclomine—Loss of consciousness—Sorafenib—liver cancer	0.000796	0.0091	CcSEcCtD
Dicyclomine—Hypertension—Sorafenib—liver cancer	0.000782	0.00894	CcSEcCtD
Dicyclomine—Injection site reaction—Epirubicin—liver cancer	0.000761	0.0087	CcSEcCtD
Dicyclomine—Dry mouth—Sorafenib—liver cancer	0.000754	0.00862	CcSEcCtD
Dicyclomine—Dyskinesia—Doxorubicin—liver cancer	0.000754	0.00862	CcSEcCtD
Dicyclomine—Anaphylactic shock—Sorafenib—liver cancer	0.000739	0.00845	CcSEcCtD
Dicyclomine—Shock—Sorafenib—liver cancer	0.000727	0.00831	CcSEcCtD
Dicyclomine—Nervous system disorder—Sorafenib—liver cancer	0.000725	0.00828	CcSEcCtD
Dicyclomine—Anorexia—Sorafenib—liver cancer	0.000704	0.00805	CcSEcCtD
Dicyclomine—Injection site reaction—Doxorubicin—liver cancer	0.000704	0.00805	CcSEcCtD
Dicyclomine—Dyspnoea—Sorafenib—liver cancer	0.000659	0.00753	CcSEcCtD
Dicyclomine—Dyspepsia—Sorafenib—liver cancer	0.000651	0.00744	CcSEcCtD
Dicyclomine—Decreased appetite—Sorafenib—liver cancer	0.000642	0.00734	CcSEcCtD
Dicyclomine—Thrombophlebitis—Epirubicin—liver cancer	0.000642	0.00734	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000638	0.00729	CcSEcCtD
Dicyclomine—Fatigue—Sorafenib—liver cancer	0.000637	0.00728	CcSEcCtD
Dicyclomine—Pain—Sorafenib—liver cancer	0.000632	0.00722	CcSEcCtD
Dicyclomine—Constipation—Sorafenib—liver cancer	0.000632	0.00722	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Sorafenib—liver cancer	0.000604	0.00691	CcSEcCtD
Dicyclomine—Thrombophlebitis—Doxorubicin—liver cancer	0.000594	0.00679	CcSEcCtD
Dicyclomine—Urticaria—Sorafenib—liver cancer	0.000587	0.00671	CcSEcCtD
Dicyclomine—Abdominal pain—Sorafenib—liver cancer	0.000584	0.00668	CcSEcCtD
Dicyclomine—Lethargy—Epirubicin—liver cancer	0.000567	0.00648	CcSEcCtD
Dicyclomine—Diplopia—Epirubicin—liver cancer	0.000556	0.00635	CcSEcCtD
Dicyclomine—Affect lability—Epirubicin—liver cancer	0.000547	0.00625	CcSEcCtD
Dicyclomine—Hypersensitivity—Sorafenib—liver cancer	0.000545	0.00622	CcSEcCtD
Dicyclomine—Face oedema—Epirubicin—liver cancer	0.000536	0.00613	CcSEcCtD
Dicyclomine—Asthenia—Sorafenib—liver cancer	0.00053	0.00606	CcSEcCtD
Dicyclomine—Mood swings—Epirubicin—liver cancer	0.000526	0.00602	CcSEcCtD
Dicyclomine—Lethargy—Doxorubicin—liver cancer	0.000525	0.006	CcSEcCtD
Dicyclomine—Pruritus—Sorafenib—liver cancer	0.000523	0.00598	CcSEcCtD
Dicyclomine—Diplopia—Doxorubicin—liver cancer	0.000514	0.00588	CcSEcCtD
Dicyclomine—Affect lability—Doxorubicin—liver cancer	0.000506	0.00579	CcSEcCtD
Dicyclomine—Breast disorder—Epirubicin—liver cancer	0.000502	0.00574	CcSEcCtD
Dicyclomine—Face oedema—Doxorubicin—liver cancer	0.000496	0.00567	CcSEcCtD
Dicyclomine—Muscular weakness—Epirubicin—liver cancer	0.00049	0.0056	CcSEcCtD
Dicyclomine—Dizziness—Sorafenib—liver cancer	0.000489	0.00559	CcSEcCtD
Dicyclomine—Mood swings—Doxorubicin—liver cancer	0.000487	0.00557	CcSEcCtD
Dicyclomine—Abdominal distension—Epirubicin—liver cancer	0.000484	0.00553	CcSEcCtD
Dicyclomine—Vomiting—Sorafenib—liver cancer	0.00047	0.00537	CcSEcCtD
Dicyclomine—Rash—Sorafenib—liver cancer	0.000466	0.00533	CcSEcCtD
Dicyclomine—Dermatitis—Sorafenib—liver cancer	0.000466	0.00532	CcSEcCtD
Dicyclomine—Breast disorder—Doxorubicin—liver cancer	0.000465	0.00531	CcSEcCtD
Dicyclomine—Headache—Sorafenib—liver cancer	0.000463	0.00529	CcSEcCtD
Dicyclomine—Muscular weakness—Doxorubicin—liver cancer	0.000454	0.00518	CcSEcCtD
Dicyclomine—Abdominal distension—Doxorubicin—liver cancer	0.000447	0.00511	CcSEcCtD
Dicyclomine—Nausea—Sorafenib—liver cancer	0.000439	0.00502	CcSEcCtD
Dicyclomine—Drowsiness—Epirubicin—liver cancer	0.000428	0.0049	CcSEcCtD
Dicyclomine—Drowsiness—Doxorubicin—liver cancer	0.000396	0.00453	CcSEcCtD
Dicyclomine—Hypoaesthesia—Epirubicin—liver cancer	0.000383	0.00437	CcSEcCtD
Dicyclomine—Eye disorder—Epirubicin—liver cancer	0.000359	0.00411	CcSEcCtD
Dicyclomine—Cardiac disorder—Epirubicin—liver cancer	0.000357	0.00408	CcSEcCtD
Dicyclomine—Hypoaesthesia—Doxorubicin—liver cancer	0.000354	0.00405	CcSEcCtD
Dicyclomine—Immune system disorder—Epirubicin—liver cancer	0.000347	0.00397	CcSEcCtD
Dicyclomine—Mediastinal disorder—Epirubicin—liver cancer	0.000346	0.00396	CcSEcCtD
Dicyclomine—Mental disorder—Epirubicin—liver cancer	0.000337	0.00385	CcSEcCtD
Dicyclomine—Erythema—Epirubicin—liver cancer	0.000335	0.00383	CcSEcCtD
Dicyclomine—Eye disorder—Doxorubicin—liver cancer	0.000332	0.0038	CcSEcCtD
Dicyclomine—Cardiac disorder—Doxorubicin—liver cancer	0.00033	0.00377	CcSEcCtD
Dicyclomine—Tension—Epirubicin—liver cancer	0.000328	0.00375	CcSEcCtD
Dicyclomine—Nervousness—Epirubicin—liver cancer	0.000325	0.00372	CcSEcCtD
Dicyclomine—Immune system disorder—Doxorubicin—liver cancer	0.000321	0.00367	CcSEcCtD
Dicyclomine—Mediastinal disorder—Doxorubicin—liver cancer	0.000321	0.00366	CcSEcCtD
Dicyclomine—Vision blurred—Epirubicin—liver cancer	0.000315	0.00361	CcSEcCtD
Dicyclomine—Mental disorder—Doxorubicin—liver cancer	0.000312	0.00356	CcSEcCtD
Dicyclomine—Ill-defined disorder—Epirubicin—liver cancer	0.000311	0.00355	CcSEcCtD
Dicyclomine—Erythema—Doxorubicin—liver cancer	0.00031	0.00354	CcSEcCtD
Dicyclomine—Agitation—Epirubicin—liver cancer	0.000308	0.00352	CcSEcCtD
Dicyclomine—Tension—Doxorubicin—liver cancer	0.000304	0.00347	CcSEcCtD
Dicyclomine—Malaise—Epirubicin—liver cancer	0.000302	0.00345	CcSEcCtD
Dicyclomine—Nervousness—Doxorubicin—liver cancer	0.000301	0.00344	CcSEcCtD
Dicyclomine—Syncope—Epirubicin—liver cancer	0.0003	0.00343	CcSEcCtD
Dicyclomine—Palpitations—Epirubicin—liver cancer	0.000296	0.00338	CcSEcCtD
Dicyclomine—Loss of consciousness—Epirubicin—liver cancer	0.000294	0.00336	CcSEcCtD
Dicyclomine—Vision blurred—Doxorubicin—liver cancer	0.000292	0.00334	CcSEcCtD
Dicyclomine—Hypertension—Epirubicin—liver cancer	0.000289	0.0033	CcSEcCtD
Dicyclomine—Ill-defined disorder—Doxorubicin—liver cancer	0.000287	0.00328	CcSEcCtD
Dicyclomine—Agitation—Doxorubicin—liver cancer	0.000285	0.00325	CcSEcCtD
Dicyclomine—Discomfort—Epirubicin—liver cancer	0.000282	0.00322	CcSEcCtD
Dicyclomine—Malaise—Doxorubicin—liver cancer	0.000279	0.00319	CcSEcCtD
Dicyclomine—Dry mouth—Epirubicin—liver cancer	0.000279	0.00319	CcSEcCtD
Dicyclomine—Syncope—Doxorubicin—liver cancer	0.000278	0.00317	CcSEcCtD
Dicyclomine—Confusional state—Epirubicin—liver cancer	0.000275	0.00315	CcSEcCtD
Dicyclomine—Palpitations—Doxorubicin—liver cancer	0.000274	0.00313	CcSEcCtD
Dicyclomine—Anaphylactic shock—Epirubicin—liver cancer	0.000273	0.00312	CcSEcCtD
Dicyclomine—Oedema—Epirubicin—liver cancer	0.000273	0.00312	CcSEcCtD
Dicyclomine—Loss of consciousness—Doxorubicin—liver cancer	0.000272	0.00311	CcSEcCtD
Dicyclomine—Shock—Epirubicin—liver cancer	0.000269	0.00307	CcSEcCtD
Dicyclomine—Nervous system disorder—Epirubicin—liver cancer	0.000268	0.00306	CcSEcCtD
Dicyclomine—Hypertension—Doxorubicin—liver cancer	0.000267	0.00306	CcSEcCtD
Dicyclomine—Tachycardia—Epirubicin—liver cancer	0.000267	0.00305	CcSEcCtD
Dicyclomine—Discomfort—Doxorubicin—liver cancer	0.00026	0.00298	CcSEcCtD
Dicyclomine—Anorexia—Epirubicin—liver cancer	0.00026	0.00298	CcSEcCtD
Dicyclomine—Dry mouth—Doxorubicin—liver cancer	0.000258	0.00295	CcSEcCtD
Dicyclomine—Confusional state—Doxorubicin—liver cancer	0.000255	0.00291	CcSEcCtD
Dicyclomine—Anaphylactic shock—Doxorubicin—liver cancer	0.000253	0.00289	CcSEcCtD
Dicyclomine—Oedema—Doxorubicin—liver cancer	0.000253	0.00289	CcSEcCtD
Dicyclomine—Shock—Doxorubicin—liver cancer	0.000249	0.00284	CcSEcCtD
Dicyclomine—Nervous system disorder—Doxorubicin—liver cancer	0.000248	0.00283	CcSEcCtD
Dicyclomine—Insomnia—Epirubicin—liver cancer	0.000247	0.00282	CcSEcCtD
Dicyclomine—Tachycardia—Doxorubicin—liver cancer	0.000247	0.00282	CcSEcCtD
Dicyclomine—Paraesthesia—Epirubicin—liver cancer	0.000245	0.0028	CcSEcCtD
Dicyclomine—Dyspnoea—Epirubicin—liver cancer	0.000244	0.00278	CcSEcCtD
Dicyclomine—Somnolence—Epirubicin—liver cancer	0.000243	0.00278	CcSEcCtD
Dicyclomine—Anorexia—Doxorubicin—liver cancer	0.000241	0.00275	CcSEcCtD
Dicyclomine—Dyspepsia—Epirubicin—liver cancer	0.00024	0.00275	CcSEcCtD
Dicyclomine—Decreased appetite—Epirubicin—liver cancer	0.000237	0.00271	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000236	0.0027	CcSEcCtD
Dicyclomine—Fatigue—Epirubicin—liver cancer	0.000235	0.00269	CcSEcCtD
Dicyclomine—Pain—Epirubicin—liver cancer	0.000234	0.00267	CcSEcCtD
Dicyclomine—Constipation—Epirubicin—liver cancer	0.000234	0.00267	CcSEcCtD
Dicyclomine—Insomnia—Doxorubicin—liver cancer	0.000229	0.00261	CcSEcCtD
Dicyclomine—Paraesthesia—Doxorubicin—liver cancer	0.000227	0.00259	CcSEcCtD
Dicyclomine—Dyspnoea—Doxorubicin—liver cancer	0.000225	0.00258	CcSEcCtD
Dicyclomine—Feeling abnormal—Epirubicin—liver cancer	0.000225	0.00257	CcSEcCtD
Dicyclomine—Somnolence—Doxorubicin—liver cancer	0.000225	0.00257	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Epirubicin—liver cancer	0.000223	0.00255	CcSEcCtD
Dicyclomine—Dyspepsia—Doxorubicin—liver cancer	0.000222	0.00254	CcSEcCtD
Dicyclomine—Decreased appetite—Doxorubicin—liver cancer	0.00022	0.00251	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000218	0.00249	CcSEcCtD
Dicyclomine—Fatigue—Doxorubicin—liver cancer	0.000218	0.00249	CcSEcCtD
Dicyclomine—Urticaria—Epirubicin—liver cancer	0.000217	0.00248	CcSEcCtD
Dicyclomine—Pain—Doxorubicin—liver cancer	0.000216	0.00247	CcSEcCtD
Dicyclomine—Constipation—Doxorubicin—liver cancer	0.000216	0.00247	CcSEcCtD
Dicyclomine—Abdominal pain—Epirubicin—liver cancer	0.000216	0.00247	CcSEcCtD
Dicyclomine—Feeling abnormal—Doxorubicin—liver cancer	0.000208	0.00238	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000207	0.00236	CcSEcCtD
Dicyclomine—Hypersensitivity—Epirubicin—liver cancer	0.000201	0.0023	CcSEcCtD
Dicyclomine—Urticaria—Doxorubicin—liver cancer	0.000201	0.00229	CcSEcCtD
Dicyclomine—Abdominal pain—Doxorubicin—liver cancer	0.0002	0.00228	CcSEcCtD
Dicyclomine—Asthenia—Epirubicin—liver cancer	0.000196	0.00224	CcSEcCtD
Dicyclomine—Pruritus—Epirubicin—liver cancer	0.000193	0.00221	CcSEcCtD
Dicyclomine—Hypersensitivity—Doxorubicin—liver cancer	0.000186	0.00213	CcSEcCtD
Dicyclomine—Asthenia—Doxorubicin—liver cancer	0.000181	0.00207	CcSEcCtD
Dicyclomine—Dizziness—Epirubicin—liver cancer	0.000181	0.00206	CcSEcCtD
Dicyclomine—Pruritus—Doxorubicin—liver cancer	0.000179	0.00204	CcSEcCtD
Dicyclomine—Vomiting—Epirubicin—liver cancer	0.000174	0.00199	CcSEcCtD
Dicyclomine—Rash—Epirubicin—liver cancer	0.000172	0.00197	CcSEcCtD
Dicyclomine—Dermatitis—Epirubicin—liver cancer	0.000172	0.00197	CcSEcCtD
Dicyclomine—Headache—Epirubicin—liver cancer	0.000171	0.00196	CcSEcCtD
Dicyclomine—Dizziness—Doxorubicin—liver cancer	0.000167	0.00191	CcSEcCtD
Dicyclomine—Nausea—Epirubicin—liver cancer	0.000162	0.00185	CcSEcCtD
Dicyclomine—Vomiting—Doxorubicin—liver cancer	0.000161	0.00184	CcSEcCtD
Dicyclomine—Rash—Doxorubicin—liver cancer	0.000159	0.00182	CcSEcCtD
Dicyclomine—Dermatitis—Doxorubicin—liver cancer	0.000159	0.00182	CcSEcCtD
Dicyclomine—Headache—Doxorubicin—liver cancer	0.000158	0.00181	CcSEcCtD
Dicyclomine—Nausea—Doxorubicin—liver cancer	0.00015	0.00172	CcSEcCtD
Dicyclomine—CHRM3—GPCR downstream signaling—PRKCE—liver cancer	1.31e-05	0.000941	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—TP53—liver cancer	1.31e-05	0.000938	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTA4—liver cancer	1.3e-05	0.000934	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PRKCE—liver cancer	1.3e-05	0.000931	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	1.28e-05	0.000919	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TRIO—liver cancer	1.28e-05	0.000917	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	1.28e-05	0.000916	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TRIO—liver cancer	1.28e-05	0.000914	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTA2—liver cancer	1.27e-05	0.00091	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TRIO—liver cancer	1.26e-05	0.000905	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCR4—liver cancer	1.23e-05	0.000879	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTA1—liver cancer	1.23e-05	0.000878	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCR4—liver cancer	1.22e-05	0.000876	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HPGDS—liver cancer	1.22e-05	0.000874	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NAT2—liver cancer	1.21e-05	0.000868	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCR4—liver cancer	1.21e-05	0.000868	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—IL6—liver cancer	1.2e-05	0.000859	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PRKCE—liver cancer	1.2e-05	0.000857	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PRKCE—liver cancer	1.19e-05	0.000854	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	1.19e-05	0.00085	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	1.18e-05	0.000847	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PRKCE—liver cancer	1.18e-05	0.000846	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.17e-05	0.000835	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CSF2—liver cancer	1.17e-05	0.000835	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALDOB—liver cancer	1.16e-05	0.000833	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CSF2—liver cancer	1.16e-05	0.000832	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CSF2—liver cancer	1.15e-05	0.000824	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	1.14e-05	0.000814	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	1.13e-05	0.000811	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CRABP1—liver cancer	1.11e-05	0.000794	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PSMD10—liver cancer	1.09e-05	0.000779	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PSMA4—liver cancer	1.09e-05	0.000779	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CSF2—liver cancer	1.06e-05	0.000758	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GOT2—liver cancer	1.06e-05	0.000758	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CSF2—liver cancer	1.06e-05	0.000756	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CSF2—liver cancer	1.05e-05	0.000748	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.99e-06	0.000715	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP2E1—liver cancer	9.95e-06	0.000712	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADAM17—liver cancer	9.71e-06	0.000695	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HPGDS—liver cancer	9.7e-06	0.000694	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADAM17—liver cancer	9.68e-06	0.000693	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.64e-06	0.00069	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADAM17—liver cancer	9.58e-06	0.000686	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYCS—liver cancer	9.31e-06	0.000667	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—F2—liver cancer	9.15e-06	0.000655	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GGT1—liver cancer	9.14e-06	0.000654	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GOT1—liver cancer	9.14e-06	0.000654	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PSMA4—liver cancer	9.13e-06	0.000653	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PSMD10—liver cancer	9.13e-06	0.000653	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—F2—liver cancer	9.12e-06	0.000653	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PSMD10—liver cancer	9.1e-06	0.000651	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PSMA4—liver cancer	9.1e-06	0.000651	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—F2—liver cancer	9.03e-06	0.000647	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PSMA4—liver cancer	9.01e-06	0.000645	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PSMD10—liver cancer	9.01e-06	0.000645	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.78e-06	0.000629	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CG—liver cancer	8.76e-06	0.000627	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CG—liver cancer	8.73e-06	0.000625	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.67e-06	0.000621	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CG—liver cancer	8.64e-06	0.000619	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PSMD10—liver cancer	8.64e-06	0.000619	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PSMA4—liver cancer	8.64e-06	0.000619	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GOT2—liver cancer	8.41e-06	0.000602	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—F2—liver cancer	8.31e-06	0.000595	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—F2—liver cancer	8.28e-06	0.000593	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTP1—liver cancer	8.21e-06	0.000587	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—F2—liver cancer	8.2e-06	0.000587	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HMOX1—liver cancer	8.09e-06	0.000579	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CG—liver cancer	7.95e-06	0.000569	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CG—liver cancer	7.93e-06	0.000567	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP2E1—liver cancer	7.91e-06	0.000566	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CG—liver cancer	7.85e-06	0.000562	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CD—liver cancer	7.7e-06	0.000551	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CD—liver cancer	7.67e-06	0.000549	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.65e-06	0.000548	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CD—liver cancer	7.6e-06	0.000544	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTM1—liver cancer	7.54e-06	0.00054	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYCS—liver cancer	7.4e-06	0.000529	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GOT1—liver cancer	7.26e-06	0.00052	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GGT1—liver cancer	7.26e-06	0.00052	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP1A1—liver cancer	7.15e-06	0.000512	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCE—liver cancer	7.07e-06	0.000506	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCE—liver cancer	7.05e-06	0.000505	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	6.99e-06	0.0005	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCE—liver cancer	6.98e-06	0.0005	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CD—liver cancer	6.97e-06	0.000499	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	6.9e-06	0.000494	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	6.71e-06	0.00048	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF2—liver cancer	6.7e-06	0.00048	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CB—liver cancer	6.69e-06	0.000479	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF2—liver cancer	6.68e-06	0.000478	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—liver cancer	6.67e-06	0.000477	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	6.62e-06	0.000474	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF2—liver cancer	6.61e-06	0.000473	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARA—liver cancer	6.54e-06	0.000468	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTP1—liver cancer	6.52e-06	0.000467	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—liver cancer	6.43e-06	0.00046	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CSF2—liver cancer	6.26e-06	0.000448	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—RAF1—liver cancer	6.24e-06	0.000447	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CSF2—liver cancer	6.24e-06	0.000446	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—RAF1—liver cancer	6.22e-06	0.000445	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CSF2—liver cancer	6.18e-06	0.000442	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—H2AFX—liver cancer	6.17e-06	0.000441	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—IL2—liver cancer	6.16e-06	0.000441	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—RAF1—liver cancer	6.16e-06	0.000441	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—H2AFX—liver cancer	6.15e-06	0.00044	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—IL2—liver cancer	6.14e-06	0.00044	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	6.09e-06	0.000436	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—H2AFX—liver cancer	6.09e-06	0.000436	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—IL2—liver cancer	6.08e-06	0.000435	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	6.07e-06	0.000435	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	6.02e-06	0.000431	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTM1—liver cancer	5.99e-06	0.000429	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CG—liver cancer	5.6e-06	0.000401	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL2—liver cancer	5.6e-06	0.000401	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL2—liver cancer	5.58e-06	0.000399	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TERT—liver cancer	5.58e-06	0.000399	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TERT—liver cancer	5.56e-06	0.000398	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL2—liver cancer	5.52e-06	0.000395	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TERT—liver cancer	5.5e-06	0.000394	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—liver cancer	5.41e-06	0.000387	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—liver cancer	5.3e-06	0.000379	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARA—liver cancer	5.19e-06	0.000372	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KDR—liver cancer	5.1e-06	0.000365	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KDR—liver cancer	5.08e-06	0.000364	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK14—liver cancer	5.07e-06	0.000363	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK14—liver cancer	5.05e-06	0.000361	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KDR—liver cancer	5.03e-06	0.00036	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK14—liver cancer	5e-06	0.000358	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ESR1—liver cancer	4.97e-06	0.000356	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ESR1—liver cancer	4.95e-06	0.000355	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CD—liver cancer	4.92e-06	0.000352	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—F2—liver cancer	4.91e-06	0.000351	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ESR1—liver cancer	4.91e-06	0.000351	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—F2—liver cancer	4.89e-06	0.00035	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALB—liver cancer	4.86e-06	0.000348	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—F2—liver cancer	4.85e-06	0.000347	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CG—liver cancer	4.7e-06	0.000336	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APC—liver cancer	4.7e-06	0.000336	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CG—liver cancer	4.68e-06	0.000335	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APC—liver cancer	4.68e-06	0.000335	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.67e-06	0.000334	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CG—liver cancer	4.64e-06	0.000332	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APC—liver cancer	4.64e-06	0.000332	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CG—liver cancer	4.45e-06	0.000318	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—BRAF—liver cancer	4.42e-06	0.000316	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—BRAF—liver cancer	4.4e-06	0.000315	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—BRAF—liver cancer	4.36e-06	0.000312	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—liver cancer	4.29e-06	0.000307	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CB—liver cancer	4.29e-06	0.000307	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CD—liver cancer	4.13e-06	0.000296	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CD—liver cancer	4.12e-06	0.000295	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	4.09e-06	0.000293	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SERPINE1—liver cancer	4.08e-06	0.000292	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	4.08e-06	0.000292	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CD—liver cancer	4.08e-06	0.000292	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SERPINE1—liver cancer	4.07e-06	0.000291	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—KRAS—liver cancer	4.04e-06	0.000289	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	4.04e-06	0.000289	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SERPINE1—liver cancer	4.03e-06	0.000289	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—KRAS—liver cancer	4.03e-06	0.000288	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—KRAS—liver cancer	3.99e-06	0.000286	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CD—liver cancer	3.91e-06	0.00028	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALB—liver cancer	3.86e-06	0.000276	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	3.71e-06	0.000266	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	3.7e-06	0.000265	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RAF1—liver cancer	3.69e-06	0.000264	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RAF1—liver cancer	3.68e-06	0.000263	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	3.67e-06	0.000262	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RAF1—liver cancer	3.64e-06	0.000261	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MTOR—liver cancer	3.6e-06	0.000258	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CB—liver cancer	3.6e-06	0.000258	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MTOR—liver cancer	3.59e-06	0.000257	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CB—liver cancer	3.59e-06	0.000257	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CB—liver cancer	3.55e-06	0.000254	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MTOR—liver cancer	3.55e-06	0.000254	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HRAS—liver cancer	3.44e-06	0.000246	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HRAS—liver cancer	3.43e-06	0.000245	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CB—liver cancer	3.41e-06	0.000244	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HRAS—liver cancer	3.39e-06	0.000243	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDKN1B—liver cancer	3.38e-06	0.000242	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDKN1B—liver cancer	3.37e-06	0.000241	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT1—liver cancer	3.34e-06	0.000239	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDKN1B—liver cancer	3.33e-06	0.000239	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT1—liver cancer	3.33e-06	0.000238	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CASP3—liver cancer	3.31e-06	0.000237	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL2—liver cancer	3.31e-06	0.000237	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CASP3—liver cancer	3.3e-06	0.000236	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT1—liver cancer	3.3e-06	0.000236	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL2—liver cancer	3.3e-06	0.000236	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—liver cancer	3.29e-06	0.000235	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—liver cancer	3.28e-06	0.000235	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CASP3—liver cancer	3.27e-06	0.000234	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL2—liver cancer	3.26e-06	0.000234	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—liver cancer	3.25e-06	0.000232	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCND1—liver cancer	3.22e-06	0.000231	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—JUN—liver cancer	3.22e-06	0.00023	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCND1—liver cancer	3.21e-06	0.00023	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—JUN—liver cancer	3.21e-06	0.000229	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CTNNB1—liver cancer	3.19e-06	0.000228	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCND1—liver cancer	3.18e-06	0.000228	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CTNNB1—liver cancer	3.18e-06	0.000228	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—JUN—liver cancer	3.17e-06	0.000227	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	3.15e-06	0.000226	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—liver cancer	3.13e-06	0.000224	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—liver cancer	3.12e-06	0.000223	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDKN1A—liver cancer	3.12e-06	0.000223	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDKN1A—liver cancer	3.11e-06	0.000222	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—liver cancer	3.09e-06	0.000221	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	3.08e-06	0.00022	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK8—liver cancer	3.04e-06	0.000218	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT1—liver cancer	3.03e-06	0.000217	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK8—liver cancer	3.03e-06	0.000217	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT1—liver cancer	3.02e-06	0.000217	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK8—liver cancer	3e-06	0.000215	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT1—liver cancer	3e-06	0.000214	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—liver cancer	2.81e-06	0.000201	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—liver cancer	2.8e-06	0.0002	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—STAT3—liver cancer	2.78e-06	0.000199	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—liver cancer	2.77e-06	0.000199	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—STAT3—liver cancer	2.77e-06	0.000198	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—STAT3—liver cancer	2.75e-06	0.000197	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CA—liver cancer	2.62e-06	0.000187	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MYC—liver cancer	2.58e-06	0.000185	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFB1—liver cancer	2.58e-06	0.000185	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MYC—liver cancer	2.58e-06	0.000184	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFB1—liver cancer	2.57e-06	0.000184	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MYC—liver cancer	2.55e-06	0.000183	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFB1—liver cancer	2.55e-06	0.000182	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KRAS—liver cancer	2.39e-06	0.000171	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KRAS—liver cancer	2.38e-06	0.00017	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KRAS—liver cancer	2.36e-06	0.000169	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CA—liver cancer	2.19e-06	0.000157	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CA—liver cancer	2.19e-06	0.000157	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	2.17e-06	0.000155	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKT1—liver cancer	2.14e-06	0.000153	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TP53—liver cancer	2.12e-06	0.000152	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TP53—liver cancer	2.12e-06	0.000151	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TP53—liver cancer	2.1e-06	0.00015	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CA—liver cancer	2.08e-06	0.000149	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HRAS—liver cancer	2.03e-06	0.000145	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HRAS—liver cancer	2.02e-06	0.000145	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HRAS—liver cancer	2e-06	0.000143	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—liver cancer	1.94e-06	0.000139	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—liver cancer	1.94e-06	0.000139	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—liver cancer	1.92e-06	0.000137	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT1—liver cancer	1.79e-06	0.000128	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT1—liver cancer	1.79e-06	0.000128	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT1—liver cancer	1.77e-06	0.000127	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKT1—liver cancer	1.7e-06	0.000122	CbGpPWpGaD
